Last updated
Ipsen: Product Launch
Ipsen presented Phase II clinical trial data for corabotase, a first-in-class recombinant neuroinhibitor (RNITM) for moderate-to-severe glabellar lines, showing sustained duration of effect and high patient satisfaction at Scale 2026 Symposium in Nashville.
Source: GlobeNewswire
The leadership read
Product momentum tends to widen the sector product and commercial leadership bench strength.
Market context: The wider read — a Talent Market Index of 111.2 (Hot), up 5.2 month-on-month — shows EMEA signal flow easing (-4.4pts).
Ipsen: 2 signals in the last 90 days; 0.1% of MitchelLake's EMEA signal flow; 2 tracked across 44 days.
MitchelLake in this thematic
Also at Ipsen →
More signals across EMEA
Product Launch · EMEA
Worldpay →Worldpay's Global Payments Report 2026 indicates digital wallets projected to overtake payment cards in Swiss e-commerce by 2030, with TWINT, PayPal, and Apple Pay leading adoption.
Product Launch · EMEA
Pennylane →Pennylane is competing for SME customers in France's mandatory e-invoicing market launching in September 2026, leveraging its accounting software and expanding all-in-one financial product suite.
Product Launch · EMEA
FxPro →FxPro announced a comprehensive revision of trading conditions, eliminating spreads entirely on major CFD products including cryptocurrencies (Bitcoin, Ethereum) and equity indices.
Product Launch · EMEA
Siteimprove →Siteimprove launched a new MCP (Model Context Protocol) Server that integrates accessibility capabilities into AI workflows across Lovable, Anthropic Claude, VS Code, and Figma, enabling automated accessibility in digital experience creation.
Product Launch · EMEA
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust →UHCW NHS Trust has gone live with an interoperable digital medicines management system, representing a significant healthcare IT implementation in the UK.
Product Launch · EMEA
ST Engineering →ST Engineering secured a US$87.1 million UK defence contract to provide nine variants of 40mm high and low velocity grenades to the military.
Intelligence powered by Autonodal ↗